Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed full pipeline small index

Surgical Procedures, Operative: full-pipeline trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Surgical Procedures, Operative: 3 US clinical trials tracked, none currently recruiting.

Surgical Procedures, Operative is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), running 1 of these trials.

Enrollment posture brief

Registry condition surgical-procedures-operative

OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Surgical Procedures, Ope (th…0%
Open-enrollment share among volume-matched conditions near Surgical Procedures, Operative

Surgical Procedures, Operative has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Surgical Procedures, Operative on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Surgical Procedures, Operative is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Surgical Procedures, Operative records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cyklokapron(R) Drug
1 trials
Ecallantide Drug
1 trials
fNIR light emitting and sensing device Device
1 trials
Remifentanil Drug
1 trials
Ropivacaine Drug
1 trials
Dexmedetomidine Drug
1 trials
Bupivacaine Drug
1 trials

US sites by state

Facility locations filed on Surgical Procedures, Operative trials. A trial with sites in several states counts in each.

Texas 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Surgical Procedures, Operative page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Surgical Procedures, Operative condition card totals 3 registered trials; most-linked intervention Cyklokapron(R); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.